Attenuation of Vinblastine-Induced Apoptosis and Degradation of IκB-α in Breast Cancer Cell Line by Caspase-3 Inhibitor

方勇,吴金民,潘宏铭
DOI: https://doi.org/10.3321/j.issn:1000-4718.2009.02.002
2009-01-01
Abstract:AIM:To investigate the changes of apoptosis and activation of IκΒ-α induced by vinblastine via the blockage of caspase-3 signal transduction pathway, and to explore the possible mechanism of signal transduction pathway involving in the vinblastine-induced apoptosis. METHODS: The breast cancer cell lines Bcap37 were treated with different concentrations of vinblatine dissolved in dimethyl sulphoxide (DMSO) or caspase-3 inhibitor (DEVD-CHO, 100 μmol/L) for 3 h. The changes of the proliferation were detected by MTT methods. The apoptosis was determined by observing the internucleosomal DNA cleavage and PI staining, and the proteins of pro-caspase-3 and IκΒ-α were detected by Western blotting methods. RESULTS: The results showed that vinblastine induced the pro-caspase-3 degradation. The significantly attenuation of vinblastine-induced apoptosis in breast cancer cell line by caspase-3 inhibitor DEVD-CHO was verified by MTT assay, internucleosomal DNA cleavage and flow cytometry PI staining analysis. The IC50 was 56.8 μmol/L and 87.4 μmol/L respectively for two groups. The inhibition of vinblastine-induced phosphorylated degradation of IκΒ-α was also observed by DEVD-CHO. CONCLUSION: Based on these finding, vinblastine induces apoptosis in breast cancer cells via NF-κΒ/IκΒ signal transduction pathway, which is co-operated by caspase signal pathway. Through the blockage of caspase pathway with caspase-3 inhibitor, vinblastine-induced apoptosis and the phosphorylated degradation of IκΒ-α in breast cancer cells are suppressed greatly.
What problem does this paper attempt to address?